SB278
Federal 340-B Drug Pricing Program; impacts within the Commonwealth.
Status:
Passed
Latest Action:
March 14, 2026
Governor's Action Deadline 11:59 p.m., April 13, 2026
Chief Patron:
Kannan Srinivasan (D)
Session:
2026 Regular Session
Summary
As Passed House of Origin. Drug manufacturers; 340B Drug Pricing Program; work group.
Directs the Secretary of Health and Human Resources to convene a work group to conduct a comprehensive evaluation of the impacts of the federal 340B Drug Pricing Program within the Commonwealth, with emphasis on governance, transparency, and the availability of pharmacy services in rural and underserved areas.-
Bill History
- 01/13/2026 - Senate: Prefiled and ordered printed; Offered 01-14-2026 26102079D
- 01/13/2026 - Senate: Referred to Committee on Education and Health
- 01/20/2026 - Senate: Assigned Education sub: Health
- 01/27/2026 - Senate: Fiscal Impact Statement from Department of Planning and Budget (SB278)
- 01/28/2026 - Senate: Senate subcommittee offered
- 01/29/2026 - Senate: Senate committee offered
- 01/29/2026 - Senate: Reported from Education and Health with substitute and rereferred to Finance and Appropriations (9-Y 0-N 6-A)
- 01/29/2026 - Senate: Rereferred to Finance and Appropriations
- 01/30/2026 - Senate: Committee substitute printed 26106505D-S1
- 02/11/2026 - Senate: Reported from Finance and Appropriations with substitute (15-Y 0-N)
- 02/12/2026 - Senate: Rules suspended
- 02/12/2026 - Senate: Constitutional reading dispensed Block Vote (on 1st reading) (40-Y 0-N 0-A)
- 02/12/2026 - Senate: Passed by for the day Block Vote (Voice Vote)
- 02/13/2026 - Senate: Committee substitute printed 26107756D-S2
- 02/13/2026 - Senate: Read second time
- 02/13/2026 - Senate: Committee substitute rejected (Voice Vote)
- 02/13/2026 - Senate: Committee substitute agreed to (Voice Vote)
- 02/13/2026 - Senate: Engrossed by Senate - committee substitute (Voice Vote)
- 02/16/2026 - Senate: Read third time and passed Senate (39-Y 0-N 0-A)
- 02/19/2026 - House: Placed on Calendar
- 02/19/2026 - House: Read first time
- 02/19/2026 - House: Referred to Committee on Health and Human Services
- 02/23/2026 - House: Assigned sub: Health
- 02/23/2026 - House: Placed on Health and Human Services Agenda
- 02/23/2026 - Senate: Fiscal Impact Statement from Department of Planning and Budget (SB278)
- 02/24/2026 - House: House subcommittee offered
- 02/24/2026 - House: Subcommittee recommends reporting with amendment(s) (10-Y 0-N)
- 02/25/2026 - House: Placed on Health and Human Services Agenda
- 02/26/2026 - House: Reported from Health and Human Services with amendment(s) (21-Y 0-N)
- 03/02/2026 - House: Read second time
- 03/03/2026 - House: Read third time
- 03/03/2026 - House: committee amendments agreed to
- 03/03/2026 - House: Engrossed by House as amended
- 03/03/2026 - House: Passed House with amendments (97-Y 0-N 0-A)
- 03/05/2026 - Senate: House amendments agreed to by Senate (39-Y 0-N 0-A)
- 03/11/2026 - Senate: Enrolled
- 03/11/2026 - Senate: Bill text as passed Senate and House (SB278ER)
- 03/11/2026 - Senate: Fiscal Impact Statement from Department of Planning and Budget (SB278)
- 03/11/2026 - Senate: Signed by President
- 03/12/2026 - House: Signed by Speaker
- 03/14/2026 - Senate: Enrolled Bill communicated to Governor on March 14, 2026
- 03/14/2026 - Governor's Action Deadline 11:59 p.m., April 13, 2026
